C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01) C12N 15/48 (2006.01) C12N 15/54 (2006.01) C12N 15/64 (2006.01) C12N 15/85 (2006.01) C12Q 1/02 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2329140
This invention relates to antiviral drug susceptibility and resistance tests to be used in identifying effective drug regimens for the treatment of human immunodificiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) and further relates to the means and methods of monitoring the clinical progression of HIV infection and its response to antiretroviral therapy, particularly non-nucleoside reverse transcriptase inhibitor therapy using phenotypic susceptibility assays or genotypic assays.
La présente invention concerne des tests de susceptibilité et de résistance aux médicaments antiviraux pour la recherche de posologies médicamenteuses convenant au traitement de l'infection par le VIH et au traitement du SIDA. L'invention concerne également des moyens et des procédés permettant de faire un suivi clinique de l'évolution de l'infection par le VIH et sa réponse à la thérapie antirétrovirale, et plus particulièrement la thérapie antirétrovirale des inhibiteurs de transcriptase inverse des non-nucléosides par utilisation d'essais de susceptibilité phénotypiques ou d'essais génotypiques.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Virologic Inc.
LandOfFree
Means and methods for monitoring non-nucleoside reverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means and methods for monitoring non-nucleoside reverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means and methods for monitoring non-nucleoside reverse... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1991168